🇺🇸 FDA
Patent

US 7153882

Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof

granted A61KA61K31/325A61K31/343

Quick answer

US patent 7153882 (Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
157
CPC classes
A61K, A61K31/325, A61K31/343, A61K31/345, A61K31/381